CRH Medical Corp (TSE:CRH) was downgraded by RBC Capital Markets from an “outperform” rating to a “sector perform” rating in a research note issued on Monday. They presently have a C$8.50 target price on the stock, up from their prior target price of C$7.00. RBC Capital Markets’ price objective points to a potential upside of 13.48% from the company’s current price.

CRH has been the topic of several other research reports. Royal Bank Of Canada lifted their target price on CRH Medical Corp from C$6.50 to C$7.00 in a research note on Friday, October 28th. Bloom Burton reaffirmed a “buy” rating on shares of CRH Medical Corp in a research note on Friday, October 28th. Finally, CIBC reaffirmed an “outperform” rating on shares of CRH Medical Corp in a research note on Tuesday, September 13th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of C$7.57.

Analyst Recommendations for CRH Medical Corp (TSE:CRH)

Shares of CRH Medical Corp (TSE:CRH) opened at 7.49 on Monday. The company’s 50 day moving average price is $6.78 and its 200-day moving average price is $5.30. CRH Medical Corp has a 1-year low of $2.98 and a 1-year high of $8.48. The firm has a market cap of $541.72 million and a price-to-earnings ratio of 76.43.

TRADEMARK VIOLATION NOTICE: “CRH Medical Corp (CRH) Stock Rating Lowered by RBC Capital Markets” was posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this article on another domain, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The original version of this article can be viewed at

Receive News & Stock Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related stocks with our FREE daily email newsletter.